Dr. Agarwal's Health Care Limited has scheduled meetings for equity shareholders, secured creditors, and unsecured creditors on July 2, 2026, to approve the proposed amalgamation with Dr. Agarwal's Eye Hospital Limited. Directed by the Hon'ble National Company Law Tribunal, Chennai Bench, the meetings will consider the scheme of amalgamation under Sections 230 to 232 of the Companies Act, 2013. The company has dispatched physical letters to stakeholders whose email addresses are not registered, providing a web-link and QR code to access the notices and documents hosted on its website.

The meetings will be conducted in physical mode at The Music Academy, T.T.K. Road, Chennai. For Dr. Agarwal's Health Care Limited, the equity shareholders' meeting is set for 12:30 P.M. (IST), followed by the secured creditors' meeting at 3:00 P.M. (IST) and the unsecured creditors' meeting at 4:00 P.M. (IST). The transferor company, Dr. Agarwal's Eye Hospital Limited, will hold its meetings for equity shareholders, secured creditors, and unsecured creditors at 9:00 A.M., 10:30 A.M., and 11:30 A.M. (IST), respectively, at the same venue.

Meeting and Voting Schedule

Key dates for the equity shareholders' meeting include a cut-off date of May 22, 2026, for dispatch of notices and June 3, 2026, for determining e-voting eligibility. For secured and unsecured creditors, the cut-off date for determining eligibility is December 31, 2025. Remote e-voting for all groups opens on June 7, 2026, at 9:00 A.M. (IST) and closes on July 1, 2026, at 5:00 P.M. (IST).

Access to Documents

The notice, explanatory statement, and annexures are available on the websites of Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited. They are also accessible on the stock exchanges where the companies are listed, including BSE Limited and National Stock Exchange of India Limited. Stakeholders may request a physical copy of the notice free of cost. Thanikainathan Arumugam, Company Secretary and Compliance Officer, signed the disclosures on June 1, 2026.

Dr. Agarwal's Health Care reported a robust financial performance for the year ended March 31, 2026, with Profit After Tax (PAT) growing 52.4% year-on-year to INR 168 Crores. The company achieved a significant operational milestone, with Revenue from Operations increasing 21.6% to INR 2,080 Crores, crossing the INR 2,000 Crore mark for the first time. EBITDA for the period rose 22.2% to INR 614 Crores, with margins expanding to 28.9%. Following the announcement, the company has made the audio recording of its analyst and earnings conference call held on May 21, 2026, available on its website.

Annual Financial Performance

The audited consolidated financial results highlight strong growth across key metrics. Total Income for the year stood at INR 2,125 Crores, a 20.9% increase compared to the previous year. The company maintained its operational efficiency, with EBITDA margins improving slightly from 28.6% in FY25 to 28.9% in FY26. Net profit margins also saw a significant rise, reaching 7.9% for the year.

Operational Expansion

During FY26, the company expanded its network significantly, adding 57 new centers to take its total facility count to 288 across 10 countries. This included 30 surgical centers, strengthening clinical capacity. The company performed 323,245 surgeries during the year, reflecting a 14.5% growth in patient volumes. The entry into the Delhi NCR region was a key highlight, with six facilities becoming operational within twelve months.

Q4 Performance Highlights

For the quarter ended March 31, 2026, the company reported a Revenue from Operations of INR 564 Crores, up 22.6% year-on-year. Net profit for the quarter stood at INR 50 Crores, growing 17.4% YoY. EBITDA for Q4 FY26 was INR 174 Crores, with margins at 30.2%. The company added 19 new centers during the quarter alone, comprising 7 secondary and 12 primary facilities.